Lipid abnormalities in atopic skin are driven by type 2 cytokines
Sphingolipid
DOI:
10.1172/jci.insight.98006
Publication Date:
2018-02-21T16:00:58Z
AUTHORS (14)
ABSTRACT
Lipids in the stratum corneum of atopic dermatitis (AD) patients differ substantially composition from healthy subjects. We hypothesized that hyperactivated type 2 immune response alters AD skin lipid metabolism. have analyzed lipids nonlesional and lesional subjects IL-13 skin-specific Tg mice. also directly examined effects IL-4/IL-13 on human keratinocytes vitro. Mass spectrometric analysis mice revealed an increased proportion short-chain (N-14:0 to N-24:0) NS ceramides, sphingomyelins, 14:0-22:0 lysophosphatidylcholines (14:0-22:0 LPC) with a simultaneous decline corresponding long-chain species (N-26:0 N-32:0 sphingolipids 24:0-30:0 when compared controls. An increase LPC was observed skin. Similar changes were IL-4/IL-13-driven responses Ca2+-differentiated vitro, all being blocked by STAT6 silencing siRNA. RNA sequencing performed as identified decreased expression fatty acid elongases ELOVL3 ELOVL6 contributed lipids. inhibited keratinocyte cultures STAT6-dependent manner. Downregulation ELOVL3/ELOVL6 siRNA acids globally sphingolipids. Thus, our data strongly support pathogenic role activation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (211)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....